Identification of a CD4-binding site-directed antibody with ADCC activity from a chronic HIV-1B'-infected Chinese donor.

Virus Research
Yuanyuan HuZheng Wang

Abstract

Antibody-dependent cell-mediated cytotoxicity (ADCC) plays an important role in controlling HIV-1 invasion and replication in vivo. Isolation and identification of monoclonal antibodies (mAbs) with ADCC activity help design effective vaccines and develop novel treatment strategies. In this study, we first identified a broad neutralizer who had been infected with an HIV-1B' strain for over 10 years. Next, through probe-specific single-B-cell sorting and PCR amplification, we obtained genes for variable regions of the heavy chain (VHs) and light chain (VLs) of six antibodies and ligated them into expression vectors. After antibody expression and ELISA screening, we obtained a CD4-binding site-directed antibody (451-B4), whose VH and VL originated from the IGHV1-24 and IGLV1-40 germlines, respectively. Although 451-B4 neutralized only the SF162 tier 1 pseudovirus and 398F1 tier 2 pseudovirus, it could mediate comparable ADCC activity to a broadly neutralizing antibody, VRC01. The 451-B4 antibody will be a useful candidate for developing an ADCC-based treatment strategy against HIV-1 replication or latent infection in vivo.

References

Feb 9, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·V Raúl Gómez-RománMarjorie Robert-Guroff
Oct 22, 2009·The New England Journal of Medicine·Supachai Rerks-NgarmUNKNOWN MOPH-TAVEG Investigators
Apr 6, 2012·The New England Journal of Medicine·Barton F HaynesJerome H Kim
Jul 31, 2012·Journal of Immunological Methods·M KramskiS J Kent
Dec 15, 2012·Proceedings of the National Academy of Sciences of the United States of America·Yongjun GuanGeorge K Lewis
Mar 13, 2015·The Journal of General Virology·Hanna DrejaÁine McKnight
Jan 1, 2013·Vaccines·Quentin J Sattentau
Dec 15, 2015·Journal of Virology·Wen Shi LeeStephen J Kent
Mar 5, 2016·Nature Communications·Timothée BruelOlivier Schwartz
Sep 28, 2016·Scientific Reports·Wei Hseun YeapSiew Cheng Wong
Jun 9, 2017·Nature Communications·Todd BradleyBarton F Haynes
Oct 21, 2017·JAMA : the Journal of the American Medical Association·Anthony S Fauci
Nov 23, 2017·Trends in Microbiology·Jonathan RichardAndrés Finzi
Dec 2, 2017·Current Opinion in HIV and AIDS·Wen Shi Lee, Stephen J Kent
Apr 29, 2020·Annual Review of Immunology·Kathryn E StephensonDan H Barouch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.